Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: publications linking product attributes threshold pricing model how commercial thresholds can inform
… at RTI Health Solutions will be attending as well. You can reach out to Evangelia or Shahnaz using the links below. …
… This enhances brevity and avoids duplicating information. How does version 5.0 of the AMCP Format address health … contributes significantly to the knowledge base of the product as study summaries and evidence tables. Include … needs, recommended for digital therapeutics in the Product Information section. It is important to note that the …
… introduce specialized machine learning database tools that can identify historically underserved populations and uncover …
… Multiple Rare Diseases OPPORTUNITY Our client had a product in multiple phase 2 and 3 clinical trials for the … treatments (pipeline and supportive care). created the product value proposition and potential value messages … plan detailing the evidence and budget needed to help inform future work. We designed the HEOR strategy plans to …
… acknowledge the role patient-preference research can play in patient-focused drug development. The growing … interpretation, and use of patient preference information can support more inclusive and equitable health outcomes. …
… generation Real-world evidence plays a critical role in product strategy and healthcare decision-making. With our … strategic decisions. Contact us to learn more about how we can help you with the real-world evidence you need to …
… are already being felt. Government negotiation of drug pricing within the Medicare system is becoming a reality. The … requirements and procedures for HTAs, market access, and pricing across Europe. Drug developers have been operating …
… care resources and face higher costs than patients who can control their condition with anti-epileptic drugs (AEDs). … patients using VNS therapy. The team developed an economic model to compare the expected costs and health outcomes for … relatively short time period. VNS, a proven intervention, can be a cost-effective, long-term solution for people with …
… improve health equity and reduce disparities. Not only can RTI Rarity’s LSI scores identify socially vulnerable … who are at high risk of poor health outcomes, it can uncover the underlying social, behavioral, and contextual …
Collaborative Regulatory RWE Research Through our Barcelona based team, we are a partner center of the European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP) which is led by the European Medicines Agency. We are dedicated to …